Welcome to our dedicated page for Surgery Partners news (Ticker: SGRY), a resource for investors and traders seeking the latest updates and insights on Surgery Partners stock.
Surgery Partners, Inc. reports developments tied to its short-stay surgical facility network and outpatient delivery model. The company provides surgical and related ancillary care through ambulatory surgery centers, surgical hospitals, anesthesia services, multi-specialty physician practices and urgent care facilities, with revenue tied to patient care services and facility case activity.
Recurring SGRY news includes quarterly results, same-facility revenue and case trends, adjusted EBITDA and guidance, operational initiatives, portfolio optimization, acquisition activity, financing and leverage actions, share repurchase authorizations, board composition and shareholder communications involving the company’s strategic direction.
Summary not available.
Summary not available.
Summary not available.
Surgery Partners (NASDAQ:SGRY) will release its first quarter 2023 results on May 1, 2023, after market close. A conference call is scheduled for the same day at 5:00 p.m. ET. Interested parties can participate via a dial-in number or by accessing a live webcast on the Company's Investor Relations website. Surgery Partners is a prominent healthcare services provider, specializing in outpatient surgical care with over 180 locations across 31 states. The company aims to deliver high-quality, cost-effective solutions in surgical and related ancillary care.
Surgery Partners (SGRY) reported a revenue increase of 15.9% to $707.1 million for Q4 2022 and 14.1% to $2.5 billion for the full year. Despite strong revenue growth, the company faced a net loss of $23.4 million for Q4 2022 and $54.6 million for the full year. Adjusted EBITDA rose by 5.6% to $120.8 million in Q4 and 12.0% to $380.2 million for the full year. The company anticipates 2023 revenues greater than $2.75 billion and Adjusted EBITDA exceeding $425 million.
Surgery Partners, Inc. (NASDAQ:SGRY) announced that it will release its fourth quarter 2022 results on March 1, 2023, before the market opens. A conference call will follow at 8:30 a.m. ET, where investors can access the live call by dialing 1-877-451-6152 for domestic calls and 1-201-389-0879 for international attendees. A replay will be available after the call until March 15, 2023. Surgery Partners is a prominent name in the healthcare sector, operating over 180 locations across 31 states. For more information, visit their website at www.surgerypartners.com.
Surgery Partners (NASDAQ:SGRY) is reaffirming its 2022 financial guidance during the J.P. Morgan Healthcare Conference on January 9, 2023. The company projects an Adjusted EBITDA of $375 million to $385 million and revenue of $2.50 billion to $2.55 billion. Headquartered in Brentwood, TN, Surgery Partners operates over 180 locations across 31 states, focusing on high-quality, cost-effective surgical services. The company acknowledges risks including COVID-19 impacts, economic conditions, and potential delays in financial closing procedures, which may affect actual results.
Surgery Partners, Inc. (NASDAQ:SGRY), a prominent healthcare services provider, will present at the J.P. Morgan Healthcare Conference on January 9, 2023, at 8:15 PM ET. Key executives, including Wayne S. DeVeydt, Eric Evans, and Dave Doherty, will engage with investors during this event. A live webcast of the presentation is accessible via the company’s Investor Relations website, with a replay available afterward. Founded in 2004 and headquartered in Brentwood, Tennessee, Surgery Partners operates over 180 locations across 31 states, delivering high-quality surgical and ancillary care.
Surgery Partners (NASDAQ:SGRY) reported third-quarter 2022 revenue of $620.6 million, a rise of 11.0% year-over-year. Same-facility revenues grew by 5.1%. Despite a net loss of $25.0 million, Adjusted EBITDA increased by nearly 26% to $96.2 million, with margins at 15.5%. The company reaffirmed its 2022 Adjusted EBITDA projection of $375 million to $385 million, and revenue expectations between $2.5 billion and $2.55 billion. The results were influenced by Hurricane Ian's impact on Florida operations, but strong operational performance and continued acquisitions helped maintain growth.
Surgery Partners, Inc. (NASDAQ:SGRY) announced that it will release its third quarter 2022 results before the market opens on November 8, 2022. This will be followed by a conference call at 8:30 a.m. Eastern Time. Interested participants can join the call via a domestic dial-in number at 1-877-451-6152 or an international line at 1-201-389-0879. A replay will be available shortly after the call until November 22, 2022. Surgery Partners operates over 180 surgical facilities across 32 states, focusing on cost-effective surgical solutions for patients and physicians.